Spots Global Cancer Trial Database for PD-1 Antibody for Reactive EBV After BMT
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: PD-1 Antibody for Reactive EBV After BMT
Official Title: Reactivation of EBV for Patients With CAEBV and EBV Associated HLH After Transplantation
Study ID: NCT04690036
Interventions
Study Description
Brief Summary: PD-1 antibody for reactivation of EBV after transplantation in patients with CAEBV/EBV-HLH
Detailed Description: Transplantaion is recongnized as a cure for CAEBV and EBV associated HLH，however, many patients undergo the reactivation of EBV after transpaltion, patiens may at high risk for recurrence of the disease. PD-1 is a promising therapy to solve this problem. The present study was a one-arm clinical study, the main subject is to evaluate the effect of PD-1 antibody on the clearance of EBV
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
Contact Details
Name: Zhao Wang
Affiliation: Beijing Friendship Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
